Annual Operating Profit
-$45.62 M
-$20.42 M-81.04%
December 31, 2024
Summary
- As of March 10, 2025, KNSA annual operating income is -$45.62 million, with the most recent change of -$20.42 million (-81.04%) on December 31, 2024.
- During the last 3 years, KNSA annual operating profit has risen by +$111.02 million (+70.88%).
- KNSA annual operating profit is now -566.76% below its all-time high of $9.77 million, reached on December 31, 2022.
Performance
KNSA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$19.30 M
-$9.64 M-99.82%
December 31, 2024
Summary
- As of March 10, 2025, KNSA quarterly operating income is -$19.30 million, with the most recent change of -$9.64 million (-99.82%) on December 31, 2024.
- Over the past year, KNSA quarterly operating profit has stayed the same.
- KNSA quarterly operating profit is now -141.58% below its all-time high of $46.41 million, reached on September 30, 2022.
Performance
KNSA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$45.62 M
-$19.38 M-73.87%
December 31, 2024
Summary
- As of March 10, 2025, KNSA TTM operating income is -$45.62 million, with the most recent change of -$19.38 million (-73.87%) on December 31, 2024.
- Over the past year, KNSA TTM operating profit has stayed the same.
- KNSA TTM operating profit is now -219.70% below its all-time high of $38.11 million, reached on June 30, 2023.
Performance
KNSA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
KNSA Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -81.0% | 0.0% | 0.0% |
| 3 y3 years | +70.9% | +46.6% | +70.9% |
| 5 y5 years | +73.2% | +40.8% | +73.2% |
KNSA Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -566.8% | +70.9% | -141.6% | +46.6% | -219.7% | +70.9% |
| 5 y | 5-year | -566.8% | +73.2% | -141.6% | +63.5% | -219.7% | +75.5% |
| alltime | all time | -566.8% | +73.2% | -141.6% | +71.5% | -219.7% | +75.5% |
Kiniksa Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$45.62 M(+81.0%) | -$19.30 M(+99.8%) | -$45.62 M(+73.9%) |
| Sep 2024 | - | -$9.66 M(+8154.7%) | -$26.24 M(-4.6%) |
| Jun 2024 | - | -$117.00 K(-99.3%) | -$27.50 M(-9.9%) |
| Mar 2024 | - | -$16.54 M(<-9900.0%) | -$30.54 M(+21.2%) |
| Dec 2023 | -$25.20 M(-357.8%) | $81.00 K(-100.7%) | -$25.20 M(+31.0%) |
| Sep 2023 | - | -$10.93 M(+246.4%) | -$19.23 M(-150.5%) |
| Jun 2023 | - | -$3.15 M(-71.8%) | $38.11 M(+74.1%) |
| Mar 2023 | - | -$11.20 M(-285.1%) | $21.90 M(+124.0%) |
| Dec 2022 | $9.77 M(-106.2%) | $6.05 M(-87.0%) | $9.77 M(-130.2%) |
| Sep 2022 | - | $46.41 M(-339.6%) | -$32.41 M(-70.4%) |
| Jun 2022 | - | -$19.37 M(-16.9%) | -$109.48 M(-16.2%) |
| Mar 2022 | - | -$23.32 M(-35.5%) | -$130.67 M(-16.6%) |
| Dec 2021 | -$156.64 M(-0.5%) | -$36.13 M(+17.8%) | -$156.64 M(-9.7%) |
| Sep 2021 | - | -$30.67 M(-24.4%) | -$173.40 M(-6.7%) |
| Jun 2021 | - | -$40.55 M(-17.7%) | -$185.95 M(+4.9%) |
| Mar 2021 | - | -$49.28 M(-6.8%) | -$177.26 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$157.36 M(-7.4%) | -$52.90 M(+22.4%) | -$157.36 M(+14.8%) |
| Sep 2020 | - | -$43.22 M(+35.6%) | -$137.05 M(+10.3%) |
| Jun 2020 | - | -$31.86 M(+8.4%) | -$124.27 M(-5.6%) |
| Mar 2020 | - | -$29.39 M(-9.8%) | -$131.70 M(-22.5%) |
| Dec 2019 | -$169.96 M(+57.1%) | -$32.58 M(+7.0%) | -$169.96 M(-6.4%) |
| Sep 2019 | - | -$30.45 M(-22.5%) | -$181.52 M(+2.4%) |
| Jun 2019 | - | -$39.29 M(-41.9%) | -$177.23 M(+11.1%) |
| Mar 2019 | - | -$67.65 M(+53.3%) | -$159.47 M(+47.4%) |
| Dec 2018 | -$108.16 M(+65.4%) | -$44.13 M(+68.7%) | -$108.16 M(+11.8%) |
| Sep 2018 | - | -$26.16 M(+21.5%) | -$96.74 M(+11.4%) |
| Jun 2018 | - | -$21.53 M(+31.7%) | -$86.83 M(+13.2%) |
| Mar 2018 | - | -$16.34 M(-50.0%) | -$76.69 M(+17.3%) |
| Dec 2017 | -$65.40 M(+172.5%) | -$32.71 M(+101.3%) | -$65.40 M(+100.1%) |
| Sep 2017 | - | -$16.25 M(+42.6%) | -$32.69 M(+98.8%) |
| Jun 2017 | - | -$11.39 M(+125.7%) | -$16.44 M(+225.7%) |
| Mar 2017 | - | -$5.05 M | -$5.05 M |
| Dec 2016 | -$24.00 M | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual operating profit year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly operating profit year-on-year change?
- What is Kiniksa Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM operating profit year-on-year change?
What is Kiniksa Pharmaceuticals annual operating income?
The current annual operating profit of KNSA is -$45.62 M
What is the all time high annual operating profit for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual operating income is $9.77 M
What is Kiniksa Pharmaceuticals annual operating profit year-on-year change?
Over the past year, KNSA annual operating income has changed by -$20.42 M (-81.04%)
What is Kiniksa Pharmaceuticals quarterly operating income?
The current quarterly operating profit of KNSA is -$19.30 M
What is the all time high quarterly operating profit for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly operating income is $46.41 M
What is Kiniksa Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, KNSA quarterly operating income has changed by $0.00 (0.00%)
What is Kiniksa Pharmaceuticals TTM operating income?
The current TTM operating profit of KNSA is -$45.62 M
What is the all time high TTM operating profit for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM operating income is $38.11 M
What is Kiniksa Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, KNSA TTM operating income has changed by $0.00 (0.00%)